# Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery Lesions

> **NCT02229864** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 12 (actual)

## Conditions studied

- Coronary Artery Disease
- Coronary Artery Stenosis
- Coronary Disease
- Coronary Stenosis

## Interventions

- **DEVICE:** Coronary artery stenting: Absorb BVS

## Key facts

- **NCT ID:** NCT02229864
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2014-10
- **Final completion:** 2019-10-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02229864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02229864, "Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery Lesions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02229864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*